Stay updated on ARV-471 plus Everolimus in ER+, HER2- Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the ARV-471 plus Everolimus in ER+, HER2- Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARV-471 plus Everolimus in ER+, HER2- Breast Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A sitewide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and links to transition updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T14:01:01.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The error page’s footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T14:31:01.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T15:13:11.000Z thumbnail image
  4. Check
    21 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Added a 403 Forbidden error page state with basic HTML boilerplate, indicating access is blocked; the surrounding site chrome remains visible, meaning this is an access issue rather than a content update.
    Difference
    17%
    Check dated 2026-09-20T20:16:27.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page now shows a new revision tag indicating a minor update to the page version. No changes to the study details or eligibility criteria are evident from this update.
    Difference
    0.1%
    Check dated 2026-08-30T21:43:38.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Results status updated from 'No Results Posted' to 'Results Submitted'. This indicates that the trial results have been prepared and submitted for posting.
    Difference
    0.1%
    Check dated 2026-08-16T15:38:19.000Z thumbnail image

Stay in the know with updates to ARV-471 plus Everolimus in ER+, HER2- Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARV-471 plus Everolimus in ER+, HER2- Breast Cancer Clinical Trial page.